THE WOODLANDS, Texas, Sept. 1, 2011 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX)today announced it will present an update on its Androxal® and Proellex® clinical programs at the Rodman and Renshaw Annual Global Investment Conference on Monday, September 12, 2011 at 10:50 am. The presentation will focus on the Androxal® program, which the Company believes is its most important near-term value driver. Slides will be available on the Company’s web site at http://www.reprosrx.com shortly before the presentation.
